AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析

◆英語タイトル:AES Gener SA (AESGENER) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12944
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:チリ
◆産業分野:電力
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AES Gener SA (AESGENER) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AES Gener SA (AES Gener) is an integrated electric utility. It produces, markets, exports and imports electric power. The company generates electricity using coal, gas, diesel, hydro, biomass and solar sources. AES Gener provides electricity in four independent markets: SIC and SING in Chile; SIN in Colombia; and SADI in Argentina. It owns energy storage and water desalination assets; and has interests in various water and power projects under construction phases. AES Gener operates a portfolio of generation assets in Chile, Colombia, and Argentina. The company is owned by AES Corp, Chilean Pension Funds and other shareholders. AES Gener is headquartered in Santiago, Chile.

AES Gener SA Key Recent Developments

Nov 27,2018: AES Gener wins tender to build Ecopetrol solar park in Colombia

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
AES Gener SA – Key Facts 5
AES Gener SA – Key Employees 6
AES Gener SA – Major Products and Services 7
AES Gener SA – History 8
AES Gener SA – Company Statement 10
AES Gener SA – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
AES Gener SA – Business Description 14
AES Gener SA – SWOT Analysis 15
SWOT Analysis – Overview 15
AES Gener SA – Strengths 15
AES Gener SA – Weaknesses 16
AES Gener SA – Opportunities 17
AES Gener SA – Threats 18
AES Gener SA – Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios – Capital Market Ratios 20
Financial Ratios – Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Power Financial Deals and Alliances 27
AES Gener SA, Power, Deals By Year, 2013 to YTD 2019 27
AES Gener SA, Power, Deals By Type, 2013 to YTD 2019 28
AES Gener SA, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Nov 27, 2018: AES Gener wins tender to build Ecopetrol solar park in Colombia 30
Section 6 – Appendix 31
Methodology 31
Ratio Definitions 31
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
AES Gener SA, Key Facts 5
AES Gener SA, Key Employees 6
AES Gener SA, Major Products and Services 7
AES Gener SA, History 8
AES Gener SA, Subsidiaries 12
AES Gener SA, Key Competitors 19
AES Gener SA, Ratios based on current share price 20
AES Gener SA, Annual Ratios 21
AES Gener SA, Annual Ratios (Cont...1) 22
AES Gener SA, Annual Ratios (Cont...2) 23
AES Gener SA, Interim Ratios 25
AES Gener SA, Power, Deals By Year, 2013 to YTD 2019 27
AES Gener SA, Power, Deals By Type, 2013 to YTD 2019 28
AES Gener SA, Recent Deals Summary 29
Currency Codes 31
Capital Market Ratios 31
Equity Ratios 32
Profitability Ratios 32
Cost Ratios 33
Liquidity Ratios 33
Leverage Ratios 34
Efficiency Ratios 34

List of Figures
AES Gener SA, Performance Chart (2013 - 2017) 24
AES Gener SA, Ratio Charts 26
AES Gener SA, Power, Deals By Year, 2013 to YTD 2019 27
AES Gener SA, Power, Deals by Type, 2013 to YTD 2019 28

★海外企業調査レポート[AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anagenesis Biotechnologies:製薬・医療:M&Aディール及び事業提携情報
    Summary Anagenesis Biotechnologies is a pharmaceutical solutions provider that offers treatment for muscle degenerative diseases. The company provides cell therapy genetics and pharmacological drugs for genetic and age related diseases. It also carries out cell-based technologies to provide solution …
  • Strongbridge Biopharma plc (SBBP):企業の財務・戦略的SWOT分析
    Summary Strongbridge Biopharma plc (Strongbridge) formerly Cortendo Plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product KEVEYIS (dichlorphenamide) is indicated for the treatment of hypokalemic, hyperkalemic …
  • Empresa Nacional del Petroleo:石油・ガス:M&Aディール及び事業提携情報
    Summary Empresa Nacional del Petroleo (ENAP) is a state-owned integrated oil and gas company. It carries out exploration, development and production of hydrocarbons. The company has major upstream operations in Magallanes region of Chile. ENAP also carries out refining, transportation, storage, and …
  • Clear Channel Outdoor Holdings Inc (CCO):企業の財務・戦略的SWOT分析
    Summary Clear Channel Outdoor Holdings Inc (Clear Channel), is an outdoor advertising company that provides creative services to smaller advertisers. The company offers services through traditional and digital display formats on roadside, urban, transit and airport environment. It also provides adve …
  • JSHP Transformer Co Ltd:企業の戦略的SWOT分析
    JSHP Transformer Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Illumina Inc (ILMN):医療機器:M&Aディール及び事業提携情報
    Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microar …
  • Serina Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Serina Therapeutics Inc (Serina Therapeutics) is a drug company that develops therapeutics for cancer, inflammation, pain, and metabolic disorders. The company’s pipeline product includes SER-214, SER-226, SER-228, SER-232, and other proprietary drugs. It uses proprietary technology, polyoxa …
  • CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Pfizer Inc.:企業の戦略・SWOT・財務情報
    Pfizer Inc. - Strategy, SWOT and Corporate Finance Report Summary Pfizer Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PNP Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PNP Therapeutics Inc (PNP Therapeutics) is a clinical-stage biopharmaceutical company that develops platform technology and products for the treatment of cancer. The company develops products for various types of cancer such as prostate, breast, colon, lung, brain, melanoma, kidney, ovarian, …
  • Larsen & Toubro Infotech Ltd (LTI):企業の財務・戦略的SWOT分析
    Larsen & Toubro Infotech Ltd (LTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • General Cable Corporation:企業の戦略・SWOT・財務情報
    General Cable Corporation - Strategy, SWOT and Corporate Finance Report Summary General Cable Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Electricity & Water Authority:企業の戦略的SWOT分析
    Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Altacor Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Altacor Ltd (Altacor) is an ophthalmology company that develops and markets orphan products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products include dry eye prescription products; dry eye retail products; products for the treatment o …
  • Canada Life Ltd:企業の戦略・SWOT・財務情報
    Canada Life Ltd - Strategy, SWOT and Corporate Finance Report Summary Canada Life Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ANGLE plc (AGL):企業の製品パイプライン分析2018
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • Kalle GmbH:企業の戦略的SWOT分析
    Kalle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • KDDI Corporation:企業の戦略・SWOT・財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Intech Biopharm Ltd (6461):製薬・医療:M&Aディール及び事業提携情報
    Summary Intech Biopharm Ltd (Intech Biopharm) is a drug developing company that develops drugs for obstructive airway diseases. The company provides marketed products such as single ingredient generics such as Synvent, and Duasma, developed for asthma; and multi-ingredient generic, Synflutide, for a …
  • Viralytics Ltd (VLA)-製薬・医療分野:企業M&A・提携分析
    Summary Viralytics Ltd (Viralytics), formerly Psiron Ltd is a provider of development and commercialisation of oncolytic immunotherapies. The company develops oncolytic immunotherapies for the treatment of different types of cancers. It offers cavataktm, a proprietary formulation for the common cold …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆